SCHEMBL21167449

SCHEMBL21167449

Cn1cc(-c2ccc(N)c(N(N)Cc3cc4ncccc4s3)n2)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 18/20 0.41
PDE3B Q13370 5/20 0.41
PDE3A Q14432 5/20 0.41
NQO2 P16083 2/20 0.41
PIP4K2C Q8TBX8 2/20 0.41
ABL1 P00519 1/20 0.41
MAPK8 P45983 1/20 0.41
MAPK10 P53779 1/20 0.41
DYRK1A Q13627 1/20 0.41
MAP3K19 Q56UN5 1/20 0.41
DYRK1B Q9Y463 1/20 0.41
PDE4C Q08493 2/20 0.38
PDE4D Q08499 2/20 0.38
PDE2A O00408 1/20 0.38
CHRM2 P08172 1/20 0.38
PDE4A P27815 1/20 0.38
PDE1A P54750 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE1C Q14123 1/20 0.38
PDE11A Q9HCR9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21167471 0.87 MET (0.42) METPDE3BPDE3APDE4CPDE4D
SCHEMBL21167577 0.77 MET (0.52) METPDE3BPDE3ANQO2PIP4K2C
SCHEMBL21167759 0.76 DYRK1A (0.40) METDYRK1APIK3CDPIK3CAPIK3CB
SCHEMBL24590984 0.76 MET (0.56) METPDE3BPDE3APDE4CPDE4D
SCHEMBL21167619 0.74 MET (0.48) METDYRK1ADYRK1B
SCHEMBL21167613 0.73 MET (0.53) METPDE3BPDE3APDE10A
SCHEMBL22475826 0.73 MET (0.52) METPDE3BPDE3APDE10A
SCHEMBL12689922 0.72 MET (0.59) METPDE3BPDE3ANQO2PIP4K2C
SCHEMBL21167337 0.72 FGFR3 (0.36) METPIK3CDPIK3CAPIK3CBPI4KA
SCHEMBL21167712 0.72 MET (0.43) METPIK3CDPIK3CAPI4KAPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3795573-B1 CERTAIN TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR HUTCHISON MEDIPHARMA LTD (CN) 2022-07-06 EP disclosed
EP-3511330-B1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS HUTCHISON MEDIPHARMA LTD (CN) 2020-09-30 EP disclosed
EP-3511330-A1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS Hutchison Medipharma Limited (CN) 2019-07-17 EP disclosed